Preventing and eradicating biofilms remains a challenge in clinical and industrial settings. Recently, the present authors demonstrated that silver oxynitrate (AgNO) prevented and eradicated single-species planktonic and biofilm populations of numerous microbes at lower concentrations than other silver (Ag) compounds. Here, the antimicrobial and anti-biofilm efficacy of AgNO is elaborated by testing its in vitro activity against combinations of dual-species, planktonic and biofilm populations of Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. As further evidence emerges that multispecies bacterial communities are more common in the environment than their single-species counterparts, this study reinforces the diverse applicability of the minimal biofilm eradication concentration (MBEC™) assay for testing antimicrobial compounds against biofilms. Furthermore, this study demonstrated that AgNO had enhanced antimicrobial and anti-biofilm activity compared to copper sulfate (CuSO) and silver nitrate (AgNO) against the tested bacterial species.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/08927014.2017.1322586 | DOI Listing |
Adv Skin Wound Care
April 2024
At the Ward of the 21st Century (W21C) Research and Innovation Centre, Calgary, Alberta, Canada, Jimena Rodriguez-Arguello, BHSc, is Research Assistant; Karin Lienhard, PhD, CCRP, is Research Associate; and Rose Geransar, PhD, is Research Manager. Ranjani Somayaji, MD, is Assistant Professor, University of Calgary. John Conly, MD, is Medical Director, W21C Research and Innovation Centre and Infectious Disease Physician and Professor, Cumming School of Medicine, University of Calgary. Chester Ho, MD, is Professor and Division Director, Division of Physical Medicine and Rehabilitation, University of Alberta. Laurie Parsons, MD, is Dermatologist and Medical Director, Southern Alberta Sheldon Chumir Wound Clinic, and Clinical Associate Professor, University of Calgary.
Objective: To evaluate the feasibility and effectiveness of a silver oxynitrate (Ag 7 NO 11 ) dressing on wound healing in patients with stalled chronic wounds.
Methods: A prospective pilot study was conducted to determine the feasibility and effect of using silver oxynitrate dressings within an outpatient setting in Alberta, Canada. A total of 23 patients (12 women and 11 men; mean age, 66.
Future Microbiol
September 2023
Department of Dental Materials & Prosthesis, Ribeirão Preto Dental School, University of São Paulo, Avenida do Café s/n, Ribeirão Preto, São Paulo, 14040-904, Brazil.
To systematically evaluate the literature on silver (Ag) gels and their antimicrobial efficacy and physicochemical stability. A search was performed in PubMed/MEDLINE, LILACS, Web of Science, Scopus, Embase and Google Scholar. Gels were formulated with Ag nanoparticles, Ag oxynitrate and colloidal Ag and showed antimicrobial activity for concentrations ranging from 0.
View Article and Find Full Text PDFSci Rep
February 2023
Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK.
Microbial growth within a wound often manifests as biofilms, which can prevent healing and is difficult to eradicate. Novel silver dressings claim to combat wound infection, but anti-biofilm efficacy and effects on healing independent of infection are often unclear. Using in vitro and in vivo S.
View Article and Find Full Text PDFJ Dent
May 2021
Department of Biomedical and Neuromotor Sciences, DIBINEM, University of Bologna - Alma Mater Studiorum, Via San Vitale 59, 40125, Bologna, Italy.
Objective: To investigate, by means of microtensile bond strength test (μTBS), nanoleakage expression analysis (NL), gelatin zymography and in situ zymography, the effects of an experimental metal salt-based zirconium oxynitrate etchant [ZrO(NO),] - ZON with two simplified adhesives on long-term bond strength and endogenous enzymatic activities.
Methods: Middle/deep coronal dentin surfaces (N = 32) were conditioned either with a traditional 37 % HPO etchant (TE) or with ZON. Further, a single-component etch-and-rinse adhesive (EF) or a universal adhesive (AU) were applied and μTBS and NL tests were performed.
Int J Pharm
April 2020
Exciton Technologies Incorporation, Edmonton, AB T5J 4P6, Canada.
Topical semi-solid formulations are ubiquitous in personal care and pharmaceutical applications. For centuries, these topical formulations have facilitated delivery of active ingredients such as botanical oils, medicinal extracts and more recently antibiotics and biologics. Numerous strategies exist for the stabilization and release of these active ingredients from semi-solid formulations, namely, inclusion of anti-oxidants and surfactants to extend shelf life and facilitate delivery respectively.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!